.png)
NextPharma is a leading European Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with sites located in Germany, France, Finland and the UK, and with healthcare logistics services in the DACH region. With expertise in solids, semi solids and non-sterile and ophthalmic liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, capsules, softgels, granules, powders, pellets, gels, creams, sprays and syrups. Each of our sites are a centre of excellence including both development and commercial capabilities with some specific niche expertise and capabilities for high potent, hormone, beta lactams, controlled drugs, lipid based and modified release formulations. The two recent sites acquisitions in France and in Scotland offer capabilities for Early Phase development, specifically for Lipid Based formulation allowing Bioavailability enhancement of challenging molecules, and the possibility to go quick into clinic thanks to the Powder in Capsules using Microdosing.